Menopause favors osteoporosis and obesity protects from it. In an attempt t
o decipher the molecular bases of these two well-known clinical observation
s, we hypothesized that they meant that bone remodeling, body weight, and r
eproduction are controlled by identical endocrine pathways. We used mouse g
enetics as a tool to translate these clinical observations into a molecular
hypothesis. The ob/ob and db/db mice were valuable models, since two of th
e three functions thought to be co-regulated are affected in these mice: th
ey are obese and hypogonadic. Surprisingly, given their hypogonadism, both
mouse mutant strains have a high bone mass phenotype. Subsequent analysis o
f the mechanism leading to this high bone mass revealed that it was due to
an increase of bone formation. All data collected indicate that, in vivo le
ptin does not act directly on osteoblasts but rather through a central path
way following binding to its specific receptors located on hypothalamic nuc
lei. This result revealed that bone remodeling, like most other homeostatic
functions, is under hypothalamic control. The nature of the signal downstr
eam of the hypothalamus is unknown but current experiments are attempting t
o identify it.